Difficulty: Medium
Average Score: 89%
Practice
Patients taking chronic doses of non-selective NSAIDs should be periodically screened for which toxicities?
Correct answer
D
Rationale
In pharmacology, particularly in the context of central nervous system (CNS) drugs, understanding the potential toxicities associated with medications is crucial for patient safety. When patients are on chronic doses of non-selective NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), it is essential to periodically screen them for various toxicities. The correct answer, option D (All of the above), is the most appropriate because non-selective NSAIDs can lead to nephrotoxicity, peripheral neuropathy, and cardiotoxicity.
Nephrotoxicity is a well-known adverse effect of NSAIDs due to their impact on renal blood flow, which can lead to acute kidney injury or exacerbate pre-existing renal conditions. Peripheral neuropathy can result from long-term NSAID use, causing nerve damage and sensory disturbances. Cardiotoxicity, including risks of hypertension, heart failure, and myocardial infarction, is also a concern with chronic NSAID use due to their effects on the cardiovascular system.
Options A, B, and C can be explained as incorrect because they do not encompass the comprehensive range of toxicities associated with chronic non-selective NSAID use. By selecting option D, healthcare providers can ensure a more thorough monitoring and management plan for patients on these medications, thereby mitigating potential risks and improving patient outcomes.
In an educational context, emphasizing the importance of routine toxicity screening for patients on chronic NSAIDs underscores the need for vigilant monitoring and early intervention to prevent or manage adverse effects. This rationale highlights the interconnectedness of pharmacology knowledge, patient care, and pharmacovigilance in promoting safe medication practices and optimizing therapeutic outcomes in clinical practice.
Nephrotoxicity is a well-known adverse effect of NSAIDs due to their impact on renal blood flow, which can lead to acute kidney injury or exacerbate pre-existing renal conditions. Peripheral neuropathy can result from long-term NSAID use, causing nerve damage and sensory disturbances. Cardiotoxicity, including risks of hypertension, heart failure, and myocardial infarction, is also a concern with chronic NSAID use due to their effects on the cardiovascular system.
Options A, B, and C can be explained as incorrect because they do not encompass the comprehensive range of toxicities associated with chronic non-selective NSAID use. By selecting option D, healthcare providers can ensure a more thorough monitoring and management plan for patients on these medications, thereby mitigating potential risks and improving patient outcomes.
In an educational context, emphasizing the importance of routine toxicity screening for patients on chronic NSAIDs underscores the need for vigilant monitoring and early intervention to prevent or manage adverse effects. This rationale highlights the interconnectedness of pharmacology knowledge, patient care, and pharmacovigilance in promoting safe medication practices and optimizing therapeutic outcomes in clinical practice.